skullcapflavone ii has been researched along with ovalbumin in 2 studies
| Studies (skullcapflavone ii) | Trials (skullcapflavone ii) | Recent Studies (post-2010) (skullcapflavone ii) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Jang, HY; Kwon, OK; Lee, HK; Oh, SR; Park, MJ | 1 |
| Bui, TT; Chai, OH; Piao, CH; Song, CH | 1 |
2 other study(ies) available for skullcapflavone ii and ovalbumin
| Article | Year |
|---|---|
Skullcapflavone II inhibits ovalbumin-induced airway inflammation in a mouse model of asthma.
Topics: Alanine Transaminase; Allergens; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Count; Collagen; Cytokines; Disease Models, Animal; Female; Flavonoids; Immunoglobulin E; Mice; Mice, Inbred BALB C; Ovalbumin; Pneumonia; Smad Proteins | 2012 |
Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Flavonoids; Histamine; Humans; Immunoglobulin E; Male; Mast Cells; Mice; Mice, Inbred BALB C; Nasal Mucosa; NF-kappa B; Ovalbumin; Rhinitis, Allergic; Th2 Cells | 2017 |